ArticleNamed Patient ProgramsNamed Patient Programs ("NPP") is one of the exceptional importation regimes of pharmaceuticals without marketing authorization ("MA") in Turkey, ...TurkeyFood, Drugs, Healthcare, Life SciencesGün + Partners
ArticlePharmacovigilance Obligations Of Marketing Authorisation HoldersHuman medicinal products are launched to market and made available for public use after going through a set of critical clinical trials ...TurkeyFood, Drugs, Healthcare, Life SciencesPaksoy
ArticleThe Decision Of The Health Services Pricing Commission And The Communiqué Amending The Social Security Institution Health Implementation Communiqué Were PublishedWith the Communiqué on Amendment to the Social Security Authority Health Implementation Communiqué ("Communiqué") and the Decision of the Health...TurkeyFood, Drugs, Healthcare, Life SciencesMoroglu Arseven
ArticleThe Regulation On Clinical Trials Of New Medicinal Products For Human Use Was PublishedWith the relevant regulation published in the Official Gazette dated 27.05.2023 and numbered 32203, the procedures and principles regarding the conduct of clinical trials and the protection of the rights of volunteers...TurkeyFood, Drugs, Healthcare, Life SciencesMoroglu Arseven
ArticleThe Turkish Medicines And Medical Devices Agency Publishes New Draft GuidelinesOn June 7, 2022, the Turkish Medicines and Medical Devices Agency ("Agency") published the Draft Guidelines on Packaging Information and Legibility of Foods for Special Medical Purposes...TurkeyFood, Drugs, Healthcare, Life SciencesELIG Gürkaynak Attorneys-at-Law
ArticleTITCK Published Guidelines For The Classification Of Diversification Applications And Variation Applications Of Licensed Medicinal Products For Human UseTurkish Pharmaceuticals and Medical Devices Agency ("TITCK") published the Guidelines for the Classification of Diversification Applications and Variation Applications ("Guidelines") on 14 April 2022. TurkeyFood, Drugs, Healthcare, Life SciencesMoroglu Arseven
ArticleTurkish Healthcare Agency Publishes Draft Regulation On Licensing Of Homeopathic Medical ProductsThe Agency has invited concerned parties to send their comments within the table format provided through the announcement through the specified e-mail address, until September 20, 2021.TurkeyFood, Drugs, Healthcare, Life SciencesELIG Gürkaynak Attorneys-at-Law
ArticleTürkiye'de İlaç, Tıbbi Cihaz Ve Sağlık Hukuku Önemli Gelişmeler Ve Öngörüler - 2021Bu yılki raporumuzda, Türkiye'de ilaç, tıbbi cihaz ve sağlık hukukunda en tartışılan ve önemli görüğümüz konuları ana hatlarıyla ele alıyoruz.TurkeyFood, Drugs, Healthcare, Life SciencesGün + Partners
ArticleTİTCK Medical Device Regulations Harmonised With The European Union LegislationAmendments to align the regulations with existing EU standards on medical devices and in vitro diagnostic devices, ensuring their applicability in Türkiye, were published on August 17, 2024.TurkeyFood, Drugs, Healthcare, Life SciencesCBC Law
ArticleTİTCK Ruhsatlı Beşerî Tıbbi Ürünlerin Çeşitleme Başvuruları Ile Varyasyon Başvurularının Sınıflandırılmasına Dair Kılavuz YayımladıTürkiye İlaç ve Tıbbi Cihaz Kurumu ("TİTCK"), Çeşitleme Başvuruları ile Varyasyon Başvurularının Sınıflandırılmasına Dair Kılavuz'u ("Kılavuz") 14 Nisan 2022 tarihinde yayımladı. TurkeyFood, Drugs, Healthcare, Life SciencesMoroglu Arseven
ArticleNew Exemption For Procurements Of The State Supply OfficeWith the Law No. 7491 published in the Official Gazette dated 28 December 2023, an additional article 12 was added to the Public Procurement Law (the "Law").TurkeyGovernment, Public SectorGün + Partners
ArticleA Milestone Decision On The Patentability Of Second Medical Use ClaimsAs per the EPC definition, a substance or composition that is already known to have been used in a "first medical use" may still be patentable for any second or further use...TurkeyIntellectual PropertyGün + Partners
ArticleNavigating Türkiye's Legal Landscape On Parallel Imports And Grey Market GoodsParallel imports and grey market goods (ie, genuine products that have been imported into a country without the trademark owner's consent, after being legitimately placed on the market elsewhere]...TurkeyIntellectual PropertyGün + Partners
ArticleSeeking Information On Pending MA Applications Is Lawful According To Administrative CourtAs per article 9 of the Regulation on Licencing, which regulates "Abridged Application", if a pharmaceutical has been licenced before, it is not necessary to repeat the tests and research and the data of these tests...TurkeyIntellectual PropertyGün + Partners
ArticleSupply Of Pharmaceutical Products From Abroad And Patent RightsThe supply of pharmaceutical products to Turkey via the named patient programme (the "NPP") is one of the exceptional importation regimes for pharmaceutical products. TurkeyIntellectual PropertyGün + Partners
ArticleTurkish Medicine And Medical Devices Agency Updates Guidelines For Scientific Meetings And Educational ActivitiesThe Turkish Medicine and Medical Devices Agency ("Agency") of the Ministry of Health issued an announcement on April 27, 2020 updating the Guidelines for Scientific Meetings and Educational...TurkeyFood, Drugs, Healthcare, Life SciencesELIG Gürkaynak Attorneys-at-Law
ArticleREGIONAL COURT OF APPEALS: The Decision Of The Turkish Medicines And Medical Devices Agency Of Refusal Of The Applications Of The Original Medicine Owners To Obtain Information On Reference Product Is UnlawfulAs per article 9 of the Regulation on Authorization, which regulates "Abridged Application", if a pharmaceutical has been authorized before, it is not necessary to repeat the tests and research, and the data of these tests doesn't have to be submitted for authorizing again.TurkeyIntellectual PropertyGün + Partners
ArticleEU Pharmaceutical Package - EU Pharmaceutical Legislative Reform And Its Impact On TürkiyeOn 26 April 2023, the European Commission (the "Commission") adopted a proposal for a new Directive and Regulation (the "Proposal") which revise and replace...European UnionIntellectual PropertyGün + Partners
ArticleTurkey’s Pharmaceutical Sector InquiryThe pharmaceutical sector has long attracted the scrutiny of antitrust authorities in many jurisdictions, mainly over major patent holders’ alleged abuse of market power. TurkeyAntitrust/Competition LawHergüner Bilgen Üçer Attorney Partnership
ArticleTwo-minute Recap Of Competition Law Matters Around The Globe – October 2022In November 2021, the CMA found that Meta's acquisition of Giphy could harm social media users and advertisers and ordered Meta to sell Giphy. After Meta's appeal, the Competition Appeal Tribunal noted that the..TurkeyAntitrust/Competition LawGen Temizer Erdogan Girgin Attorney Partnership